| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | J Zurita | |
| Latin America Working Group on Bacterial Resistance | |||
| M V Villegas | |||
| C Mejía | |||
| M J C Salles | |||
| P2860 | cites work | Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat | Q24550671 |
| International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases | Q28304595 | ||
| The CTX-M beta-lactamase pandemic. | Q30356558 | ||
| Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain | Q30396308 | ||
| CTX-M Enzymes: Origin and Diffusion | Q30415141 | ||
| Epidemiologic trends, occurrence of extended-spectrum beta-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002-2007 from the SMART study | Q33652836 | ||
| Extended-spectrum beta-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003 | Q33806371 | ||
| Bacterial resistance to antimicrobial agents in Latin America. The giant is awakening | Q33876185 | ||
| Extended-spectrum-beta-lactamase-producing Escherichia coli strains isolated from farm animals from 1999 to 2002: report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program | Q33938190 | ||
| The changing epidemiology of resistance | Q34997021 | ||
| CTX-M-14 β-lactamase-producing Citrobacter freundii isolated in Venezuela. | Q35063662 | ||
| Integrated Multilevel Surveillance of the World's Infecting Microbes and Their Resistance to Antimicrobial Agents | Q35066011 | ||
| First characterization of CTX-M-15-producing Escherichia coli ST131 and ST405 clones causing community-onset infections in South America. | Q35066516 | ||
| Clonal composition of Escherichia coli causing community-acquired urinary tract infections in the State of Rio de Janeiro, Brazil | Q35134800 | ||
| Risk factors for fecal colonization with trimethoprim-resistant and multiresistant Escherichia coli among children in day-care centers in Houston, Texas | Q35565378 | ||
| Phaeohyphomycosis of the central nervous system in immunocompetent hosts: report of a case and review of the literature | Q35600599 | ||
| In-roads to the spread of antibiotic resistance: regional patterns of microbial transmission in northern coastal Ecuador | Q35836966 | ||
| Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen. | Q36536705 | ||
| Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections | Q37028442 | ||
| Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern | Q37091253 | ||
| Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections | Q37247785 | ||
| Antibiotic resistance in Mexico: a brief overview of the current status and its causes. | Q37721091 | ||
| The challenges of antimicrobial resistance in Brazil | Q37861940 | ||
| CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia. | Q39219509 | ||
| Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. | Q42111230 | ||
| Emergence and dissemination of extended-spectrum beta-lactamase-producing Escherichia coli in the community: lessons from the study of a remote and controlled population. | Q42667350 | ||
| Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures | Q42799124 | ||
| Increasing resistance in community-acquired urinary tract infections in Latin America, five years after the implementation of national therapeutic guidelines. | Q42967692 | ||
| Increased detection of extended spectrum beta-lactamase producing Salmonella enterica and Escherichia coli isolates from poultry | Q43098115 | ||
| Urinary tract infections caused by multi-drug resistant Proteus mirabilis: Risk factors and clinical outcomes | Q43226812 | ||
| Sex, drugs, bugs, and age: rational selection of empirical therapy for outpatient urinary tract infection in an era of extensive antimicrobial resistance | Q43606086 | ||
| Increasing prevalence of extended-spectrum-beta-lactamase among Gram-negative bacilli in Latin America--2008 update from the Study for Monitoring Antimicrobial Resistance Trends (SMART). | Q43663586 | ||
| International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections | Q43699184 | ||
| Extended-spectrum beta-lactamases belonging to CTX-M group produced by Escherichia coli strains isolated from companion animals treated with enrofloxacin | Q44254762 | ||
| Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000). | Q44256805 | ||
| Ability of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY antimicrobial surveillance program (1997-2000) | Q44614083 | ||
| Antimicrobial-resistant pathogens in animals and man: prescribing, practices and policies | Q45034218 | ||
| A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. | Q45923958 | ||
| In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART). | Q46334700 | ||
| Low frequency of ertapenem-resistant intra-abdominal isolates of Escherichia coli from Latin America: susceptibility, ESBL-occurrence, and molecular characterisation (SMART 2008-2009). | Q50948247 | ||
| Trimethoprim-Resistant Escherichia coli in Households of Children Attending Day Care Centers | Q54264631 | ||
| Antibiotic resistance patterns of Escherichia coli isolates from different aquatic environmental sources in León, Nicaragua. | Q54303282 | ||
| Occurrence and characteristics of extended-spectrum-β-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses. | Q54321125 | ||
| Characterization of extended-spectrum beta-lactamases, antimicrobial resistance genes, and plasmid content in Escherichia coli isolates from different sources in Rio de Janeiro, Brazil. | Q54333405 | ||
| [Emergence of resistance to third generation cephalosporins by Enterobacteriaceae causing community-onset urinary tract infections in hospitals in Colombia]. | Q54334389 | ||
| Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from Rio de Janeiro, Brazil. | Q54358049 | ||
| Cephalosporin and fluoroquinolone combinations are highly associated with CTX-M β-lactamase-producing Escherichia coli: a case–control study in a French teaching hospital | Q54379378 | ||
| Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli. | Q54381514 | ||
| Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. | Q54434485 | ||
| Prevalence of community-occurring extended spectrum beta-lactamase-producing Enterobacteriaceae in Brazil. | Q54442537 | ||
| Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines? | Q54450564 | ||
| Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. | Q54452583 | ||
| Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection | Q82694773 | ||
| Investigating the impact of the definition of previous antibiotic exposure related to isolation of extended spectrum β-lactamase-producing Klebsiella pneumoniae | Q83264519 | ||
| [Antibacterial drug resistance in Latin America: consequences for infectious disease control] | Q83495043 | ||
| [Results of antimicrobial susceptibility surveillance in Chile: consolidating a network] | Q83988038 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bacteria | Q10876 |
| antibiotic | Q12187 | ||
| Gram-negative bacteria | Q632006 | ||
| infection | Q166231 | ||
| community-acquired infection | Q25377722 | ||
| bacterial drug resistance | Q64924127 | ||
| P304 | page(s) | 2459-2472 | |
| P577 | publication date | 2013-08-07 | |
| 2013-12-01 | |||
| P1433 | published in | Epidemiology and Infection | Q5382708 |
| P1476 | title | Resistant gram-negative infections in the outpatient setting in Latin America | |
| P478 | volume | 141 |
| Q55444694 | Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). |
| Q39396465 | Carbapenem-resistant Enterobacteriaceae in the community: a scoping review |
| Q28354075 | First Report of Group CTX-M-9 Extended Spectrum Beta-Lactamases in Escherichia coli Isolates from Pediatric Patients in Mexico |
| Q37517993 | Intra-abdominal Infections: The Role of Anaerobes, Enterococci, Fungi, and Multidrug-Resistant Organisms |
| Q93134504 | Parental Antibiotic Use in Urban and Peri-Urban Health Care Centers in Lima: A Cross-Sectional Study of Knowledge, Attitudes, and Practices |
| Q40734886 | Potential virulence of Klebsiella sp. isolates from enteral diets |
| Q37334691 | Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia |
| Q36734144 | Unexpected distribution of the fluoroquinolone-resistance gene qnrB in Escherichia coli isolates from different human and poultry origins in Ecuador |
Search more.